AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Geteka-M Tablet SR

Prescription Icon
Prescription Required

Marketer

Croise Pharma

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Geteka-M Tablet SR

Diabexe Duo SR tablets are a dual-action antidiabetic medication prescribed for adult patients with type 2 diabetes. This combination therapy helps regulate blood glucose. Diabexe Duo SR should be taken with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a rapid-acting glucose source (e.g., sugary snacks or juice) to counter hypoglycemia and maintain regular mealtimes. Alcohol consumption increases hypoglycemia risk and should be minimized. Additional potential side effects involve altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended by your doctor.

Uses of Geteka-M Tablet SR

Non-insulin-dependent diabetes

Major Benefits of Geteka-M Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Geteka-M Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Geteka-M Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Geteka-M Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the Geteka-M Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Geteka-M Tablet SR works:

Geteka-M SR tablets contain a dual-action formulation of gliclazide and metformin, both medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Geteka-M Tablet SR and alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Geteka-M Tablet SR during pregnancy is contraindicated due to established harm to the fetus. In exceptional, life-threatening cases, a physician might prescribe it when the potential benefits outweigh the known risks. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Geteka-M tablet should likely be avoided while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Geteka-M SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Geteka-M SR tablet use. Physician consultation is necessary. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Caution is advised when prescribing Geteka-M Tablet SR to individuals with hepatic impairment. Dosage modification of Geteka-M Tablet SR may be necessary. Physician consultation is recommended. For patients exhibiting mild to moderate liver dysfunction, Geteka-M Tablet SR is typically initiated at a reduced dosage; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Geteka-M Tablet SR :

Should you forget a Geteka-M Tablet SR dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual medication schedule. Avoid taking a double dose.

Facts to Know About Geteka-M Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Geteka-M Tablet SR

Geteka-M SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Geteka-M Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Geteka-M Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Geteka-M Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). While rare, this side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Geteka-M Tablet SR and seek immediate medical attention.
Prolonged Geteka-M Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Geteka-M Tablet SR is contraindicated in patients with hypersensitivity to any of its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Geteka-M Tablet SR and alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Geteka-M SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Geteka-M Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Geteka-M Tablet SR can cause low blood sugar (hypoglycemia), characterized by symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Geteka-M Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Geteka-M Tablet SR and seek immediate medical attention.
Prolonged Geteka-M Tablet SR use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Geteka-M Tablet SR is contraindicated in patients allergic to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Geteka-M Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar and increase the risk of lactic acidosis.
Geteka-M Tablet SR
50
MRP 58
13% off